19
TRANSPLANTATION OF ISOLATED LIVER CELLS IN THE TREATMENT OF LIVER-BASED METABOLIC DISEASE

TRANSPLANTATION OF ISOLATED LIVER CELLS IN THE TREATMENT OF LIVER-BASED METABOLIC DISEASE

  • Upload
    cortez

  • View
    76

  • Download
    4

Embed Size (px)

DESCRIPTION

TRANSPLANTATION OF ISOLATED LIVER CELLS IN THE TREATMENT OF LIVER-BASED METABOLIC DISEASE. Transplantation and PKU. Organ Transplantation Most people view transplantation as very risky, expensive, and experimental Questionable quality of life from immune suppression PKU - PowerPoint PPT Presentation

Citation preview

Page 1: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

TRANSPLANTATION OF ISOLATED LIVER CELLS

IN THE TREATMENT OF LIVER-BASED METABOLIC DISEASE

Page 2: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

Transplantation and PKU Organ Transplantation

• Most people view transplantation as very risky, expensive, and experimental

• Questionable quality of life from immune suppression

PKU• Most definitions of "well controlled" allow Phe levels well above

normal

• Approximately half of patients who use Kuvan (biopterin) respond Most do so only partially Typical adult dose is 10 pills/day at about $80,000 per year

• PEG-PAL (enzyme replacement) will require weekly injectionsProbable adult cost: several hundred thousand dollars/year

Page 3: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

LIVER TRANSPLANTATION Surgical Risks

Risk of Graft Loss

It is no longer 1984!

Page 4: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

Long Term Results of Liver Transplantation 1996-2007

Data from Children’s Hospital of Pittsburgh All Etiologies of Liver Disease

Page 5: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

Outcomes of >5 Year Survivors of Pediatric Liver Transplantation: SPLIT

Pediatric Academic Multi-Organ Transplantation (PAMOT) Program Hospital for Sick Children, Toronto, Canada

And EMMES Corporation, Rockville, MD, USA

Study population (N=461 Children) 54% < 2 years old - 30% > 13 years old

(13% LBMD; 11% ALF; 4% Tumor; 47% BA)

• 87% of patients still have first graft

• InfectionPTLD (6%)

• Growth and developmentHeight below 10% percentile - 29%

Weight below 10% percentile - 18%

Page 6: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

Extra-Hepatic Morbidity Extra-Hepatic Morbidity at the 5-Year Anniversaryat the 5-Year Anniversary

0

10

20

30

40

50

% o

f p

atie

nts

cGFR < 90 HTN BMI choles triglyceride

Page 7: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

Treatment of PKU

• Phenylalanine (protein restriction)

• Close monitoring of Phe levels

• Watch for unexpected Phe sources

• Life long therapy

Page 8: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

PKU Diet

• Highly restrictive• Socially and financially

burdensome• Time consuming to manage• Medical and low protein foods

are unpalatable to some• Problems with adherence• Diet for life!

Page 9: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

Consequences of Hyperphe

When PKU is untreated: Mental retardation or loss of IQ Seizures Difficulties in executive function Psychological and behavioral

issues Social difficulties Tremors Irritability Eczema

Children

When PKU is poorly controlled: • Difficulties in executive function Psychological and behavioral

issues Social difficulties Neurological complications Irritability Eczema

Adults

PKU Patients Not on Diet

PKU Patients Not on Diet

Page 10: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

Maternal PKU• Risk of fetal damage is extremely high in

uncontrolled women (Phe > 20)– 92% mental retardation– 72% microcephaly– 40% IUGR– 12% congenital heart disease

• Risks are lower with lower Phe• What is the critical threshold level?

Page 11: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

CELL TRANSPLANTATION

Minimally Invasive Therapy for Life-Threatening Diseases

Page 12: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

CRIGLER-NAJJAR SYNDROME TYPE 1HEPATOCYTE TRANSPLANTATION: LBMD

BILIRUBIN: FELL FROM 27 TO 12 MG/DL

PHOTOTx: REDUCED 30-40%

B-UGT ACTIVITY: 0.4 TO 5.5% NORMAL

BILE: 33% BILI GLUCURONIDES

Recessively InheritedAbsence of Bilirubin-UGT

Unconjugated HyperbilirubinemiaKernicterus

BILIRUBIN

30 mg/dl

0 mg/dl

DAYS 150-30

Page 13: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

HEPATOCYTE TRANSPLANTATIONCRIGLER-NAJJAR SYNDROME TYPE 1

-7 93 193 295 395 495 595 6950

5

10

15

20

25

30

Bilir

ub

in (

mg

/dl)

days

Page 14: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

CRIGLER-NAJJAR SYNDROME TYPE 1

HEPATOCYTE TRANSPLANTATION

HUMAN

GUNN RAT

LIVER-BASED METABOLIC DISEASE

Page 15: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

HEPATOCYTE TRANSPLANTATION

Treatment of Children in LBMDConditioning Regimen:

Liver-Directed RT to Right Liver Lobe

(Conditioning Similar to that Required for Bone Marrow Transplantation)

Page 16: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

8-

7-

6-

5-

4-

3-

2-

1-

0-0 4 8 12 16

Seru

m B

iliru

bin

Leve

ls (m

g/dl

)

Time after Hepatocyte Transplantation (Weeks)20 24 28

Regional RT Followed by Hepatocyte Transplantation Correction of Bilirubin levels in Gunn Rat model of CN-1

- RT to ML + LL (~60% of liver; n-8)- RT to ML + LL (~60% of liver; n-8)

- no RT (n = 4)- no RT (n = 4)

- RT to ML (~35% of liver; n = 6)- RT to ML (~35% of liver; n = 6)

Page 17: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

RISK OF LIVER IRRADIATION IN INFANTS

RT for Liver Hemangiomas - 1950s to 1980s

1/3 liver can tolerate up to 10,000 Rads

20 Liver Cancer Rare After Liver-Directed RT

National Wilm’s Tumor Study - 2438 patients

Minimal Cancer Risk Associated with High Dose RT and Chemotherapy

Page 18: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

PKU AND TRANSPLANTATION

Liver Cell Transplantation

• Providing a small percentage (5-10%) of normally functioning liver cells should provide normal PKU control with a

normal diet •Sarkissian CN, et al Molec Genet and Metab 69; 188, 2000

Hamman K et al Molec Ther 12; 337, 2005

• If immune suppression becomes an issue, it can be stopped and the native liver still functions perfectly

aside from the PAH defect

Page 19: TRANSPLANTATION  OF ISOLATED LIVER CELLS  IN THE TREATMENT OF  LIVER-BASED METABOLIC DISEASE

The Jury Is Out